$22.72 B
Share price
Change (1 day)
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: $22.72 Billion

As of June 2023 BeiGene has a market cap of $22.72 Billion. This makes BeiGene the world's 782th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2023

End of year Market Cap

Year Market cap Change
2023$22.72 B-3.12%
2022$23.46 B-14.65%
2021$27.48 B14.39%
2020$24.03 B133.57%
2019$10.28 B23.44%
2018$8.33 B87.28%
2017$4.45 B269.44%
2016$1.20 B

End of Day market cap according to different sources

On Jun 8th, 2023 the market cap of BeiGene was reported to be:

$22.72 Billion
by Yahoo Finance
$22.72 Billion
by CompaniesMarketCap
$295.77 Billion
by Nasdaq
$20.79 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$1.25 B-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.53 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA